Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts

T. Thomas, E. Casado, P. Geusens, W. F. Lems, J. Timoshanko*, D. Taylor, L. C. Hofbauer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


A panel of European experts was convened to establish consensus on a treat-to-target strategy in osteoporosis. Panellists agreed that the ultimate goals of treating osteoporosis are recovering pre-fracture functional level and reducing subsequent fracture risk; there was consensus that total hip bone mineral density is currently the most appropriate treatment target in clinical practice. Introduction A modified Delphi approach was convened to establish consensus among European experts on best practice management for patients with fragility fractures and whether a treat-to-target (T2T) strategy is applicable in osteoporosis. Methods A panel of 12 clinical experts (from eight European countries) voted on 13 final statements relating to a T2T strategy for osteoporosis across three rounds of blinded, remotely conducted electronic surveys (Likert scale: 'strongly disagree', 'disagree', 'unable to answer', 'agree', 'strongly agree'). When panellists disagreed, they were asked how the statement could be adjusted to allow for a positive response, which was used to refine the statement for the following round. Consensus was defined as >= 75% agreement with a statement. Panellists were selected by UCB Pharma, which provided financial and logistical support. Results Consensus was reached for 13/13 statements. Panellists agreed that the most important goals for fragility fracture patients are recovery of pre-fracture functional level and reduction of subsequent fracture risk. There was also consensus that a T2T strategy is applicable to osteoporosis and that bone mineral density (BMD) is currently the most clinically appropriate target. With regard to the definition of a specific BMD treatment target and timeframes applicable to T2T in osteoporosis, no clear consensus was reached; panellists emphasised that these would need to be individually determined. Conclusions According to a panel of European experts, the main goals of fracture management are to recover pre-fracture functional level and reduce fracture risk. Total hip BMD seems to be the most clinically appropriate treatment target within a T2T strategy.

Original languageEnglish
Pages (from-to)2303-2311
Number of pages9
JournalOsteoporosis International
Issue number12
Early online date7 Aug 2020
Publication statusPublished - Dec 2020


  • Bone mineral density
  • Delphi panel
  • Fragility fracture
  • Osteoporosis
  • Treat-to-target


Dive into the research topics of 'Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts'. Together they form a unique fingerprint.

Cite this